Benzinga | Oct 28, 2021 07:43AM EDT

Evelo Biosciences Q3 EPS $(0.63) Misses $(0.54) Estimate

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.54) by 16.67 percent. This is a 40 percent decrease over losses of $(0.45) per share from the same period last year.